UW News

Valerie Daggett


February 29, 2024

Q&A: How a potential treatment for Alzheimer’s disease could also work for Type 2 diabetes

Alzheimer’s disease and Type 2 diabetes are part of a family of amyloid diseases that are characterized by having proteins that cluster together. UW researchers have demonstrated more similarities between the two diseases.


December 5, 2022

New blood test can detect ‘toxic’ protein years before Alzheimer’s symptoms emerge, study shows

stylized image of the human brain

Researchers at the University of Washington have detected “toxic” small aggregates of a particular protein in the blood of individuals with Alzheimer’s disease, as well as in individuals who showed no signs of cognitive impairment at the time the blood sample was taken, but who developed it at a later date. This blood test picks up oligomers — or small, misfolded aggregates — of the amyloid beta protein, which scientists believe triggers the development of Alzheimer’s.


October 10, 2022

Engineering lecture series focuses on health care for the brain

Two people look at a slide on a microscope

The University of Washington’s annual Engineering Lecture Series will feature research with potential to transform brain therapeutics from infancy to late adulthood.


April 15, 2019

Synthetic peptide can inhibit toxicity, aggregation of protein in Alzheimer’s disease, researchers show

a chemical structure of a peptide

A team led by researchers at the University of Washington has developed synthetic peptides that target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease.


July 28, 2014

New protein structure could help treat Alzheimer’s, related diseases

An abnormal protein, left, is intercepted by the UW’s compound that can bind to the toxic protein and neutralize it, as shown at right.

University of Washington bioengineers have a designed a peptide structure that can stop the harmful changes of the body’s normal proteins into a state that’s linked to widespread diseases such as Alzheimer’s, Parkinson’s, heart disease, Type 2 diabetes and Lou Gehrig’s disease.